| |
|
|
| |
Coagulation Self-Testing
Devices, Markets, Players and Prospects
|
Publication: June 2011
Product Code: CST203V
|
The ability of patients to self-monitor is deemed to be a
critical tool in reducing the pathological effects of
difficult-to-control disease factors. For the millions of
patients in the US and worldwide prescribed warfarin for
oral anticoagulation therapy (OAT), the ability to monitor
coagulation rates and adjust drug dosage to optimize
therapeutic outcomes is a critical element of patient care.
The availability of self-testing monitors provides patients
with an opportunity to self-test and avoid frequent
caregiver visits. Compared to blood glucose monitoring, OAT
self-testing presents a higher level of complexity and risk,
placing a premium on patient education. A number of
companies are now providing services to patients wishing to
self-test, acting as a first-line patient resource and
assisting with device selection and patient training.
Wirelessly-enabled devices that allow patients to share
readings with physicians electronically provide an
additional safety and compliance benefit. While still a
small percentage of all patients, as demographics and
awareness drive increases in the diagnosed incidence of
underlying conditions, patient self-testing for OAT will
increasingly migrate from caregiver facilities and into
homes.. |
|
Highlights |
· Analyzes marketed
patient self-testing devices for measuring and
monitoring anticoagulation drug therapy
· Evaluates the status
and prospects of coagulation self-test devices currently
in development
· Assesses the market
potential and commercialization risks and opportunities
for coagulation self-test devices
· Examines the role and
impact of third-party PT/INR self-test services on
device demand and patient acceptance
· Provides market data
and forecasts to 2015
· Profiles market
participants, their technology, product
development activity, and business
strategies
|
|
Summary of Contents |
Executive Summary
Anticoagulation Therapy
Market Dynamics
Anticoagulation Economics
Oral Anticoagulation Therapy
Monitoring Prothrombin
Time
Competing Anticoagulation Tests
Key
Factors in Patient Compliance
Market Drivers
Industry Alignment and Competitive Landscape
Coagulation Self-Testing Device Design Factors
Standardization of PT/INR Testing
Accuracy
and Precision
Sampling Method
Endpoint
Detection
Patient/User Interface
Connectivity
& Data Collection
Commercialization Factors
Managed Care and Reimbursement
Patient
Training and Education
Third-Party Self-Testing
Services
Market Factors
Regulations and
Standards
Patient/Consumer Sentiment
Regional
Demand and Demographics
Alliances and
Partnerships
Proprietary Technology
Patient
Self-Testing Product Assessments
CoaguChek
CoaguSense
InRatio
ProTime
Development-Stage Devices
iLine Microsystems
Microvisk
Universal Biosensors
Zin
Technologies
Market Analysis, Data
and Forecasts
Indications and Demographics
Therapeutic Market Segments
New Technology &
Pipeline Prospects
Geographic Markets
Market Participant Profiles
|
|
|
|
|
